MeiraGTx (MGTX)
(Delayed Data from NSDQ)
$7.74 USD
-0.10 (-1.28%)
Updated Aug 5, 2025 04:00 PM ET
After-Market: $7.73 -0.01 (-0.13%) 5:42 PM ET
3-Hold of 5 3
F Value C Growth B Momentum F VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
MGTX 7.74 -0.10(-1.28%)
Will MGTX be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for MGTX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for MGTX
3 Promising Genomics Stocks to Keep an Eye On in 2025
MeiraGTx Holdings PLC (MGTX) Reports Q1 Loss, Misses Revenue Estimates
MGTX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Beam Therapeutics (BEAM) Moves 12.6% Higher: Will This Strength Last?
AnaptysBio (ANAB) Moves 9.5% Higher: Will This Strength Last?
MeiraGTx Holdings PLC (MGTX) Reports Q3 Loss, Tops Revenue Estimates
Other News for MGTX
Insider Sell Alert: Alexandria Forbes Sells 47,500 Shares of MeiraGTx Holdings PLC
Prosight Management, LP's Strategic Acquisition in Mural Oncology PLC
MeiraGTx Gains UK Approval for Hologen Transactions
Meiragtx Holdings (MGTX) Receives a New Rating from Lucid Capital
Lucid Capital Initiates Buy Rating on MeiraGTx (MGTX) with $50 Target | MGTX Stock News